An apparatus (10) for minimally-invasive, including non-invasive, prevention and/or treatment of hydrocephalus and method for use of the same are disclosed. In one embodiment of the apparatus (10), a housing (50) is sized for superjacent contact with a skull having a fontanel. Within the housing (50), a compartment (12) includes a pressure applicator (88), such as a fluid-filled bladder (22), under the control of a pressure regulator (14). The pressure applicator (88) is configured to selectively apply an external pressure to the fontanel. The compartment (12) includes a pressure sensor (90) configured to measure intracranial pulse pressure of the fontanel. Further, in one embodiment, the apparatus (10) can cause pulse pressure modulation by adjusting the intracranial pulse pressure via the pressure applicator (88). This enables a non-invasive measurement of the pulse pressure and modulation thereof in infants, for example.

Embodiments of the present specification provide surgical methods and apparatuses to deploy at least one stent through an optic nerve sheath in order to maintain an opening/fenestration for intracranial fluid egress. The surgical method creates a fenestration, an opening, a slit, or a hole, through an optic nerve sheath of a human patient. The fenestration is created in a minimally invasive manner using an applicator, such as an endoscopic visualization apparatus, that includes a stent or shunt for deploying through the fenestration. The presently disclosed specification is indicated to treat papilledema and/or intracranial hypertension and to deliver therapeutic compositions through the optic nerve sheath.

A shunt device for directing fluid from a human head, and methods thereof are provided herein. The device can be mounted at a skull and include a first catheter that extends into a portion of the head such as a lateral ventricle. The first catheter can covey fluid through, and past a valve to a shunt body. The shunt body can include openings, allowing the fluid to reenter the head, for example at the subarachnoid space. The shunt body can also include other openings that can be associated with a second catheter. Fluid can thus also be conveyed out of the body or to a subgaleal pocket.

Disclosed is s self-cleaning catheter system with self-monitoring capabilities. The catheter system includes a catheter configured to be implanted in a body cavity of a subject, a cleaning unit configured for motion within the catheter such as to mechanically prevent and/or remove or mitigate blockage of at least a section of the catheter, an implantable sensor, and an implantable controller functionally associated with the cleaning unit and configured for activation thereof. The implantable sensor is communicatively associated with the implantable controller and is configured to detect motion of the cleaning unit, and to output one or more signals indicative of the motion of the cleaning unit. The implantable controller is configured to receive the one or more signals from the implantable sensor and, based, at least, thereon, to provide at least one motion indication, at least when the one or more signals are indicative of malfunctioning of the cleaning unit.

This application discloses methods and tools for the treatment of chronic fatigue syndrome (CFS) and fibromyalgia and the use of retinal nerve fiber layer thinning as a biomarker for the treatment.

A control system and method for automatically adjusting the height of an external ventricular drain from a patient. The height of a pole supporting the bag into which the fluid is drained can be varied, increased or decreased, as driven by a motor. A drip chamber and collection bag that receive the fluid from the patient are attached to the height variable pole. An external fluid pressure tube is coupled to the patient at one end and to a pressure sensor at the other. The pressure sensor is coupled to the height variable pole. The system includes a feedback loop that adjusts the height of the external ventricular drain (EVD) to match the height of the patient's head. As the patient's head moves up or down, the variable height pole moves up and down a corresponding distance to maintain the patient's intracranial or intraspinal pressure, and therefore the cerebrospinal fluid (CSF) drainage rate, at a preset value.

A method for treatment of a brain and/or spinal cord includes inserting a flexible catheter into a cerebrospinal fluid space, the flexible catheter including two lumens adapted to allow a fluid to circulate therein in a closed loop within the flexible catheter and the flexible catheter being adapted to be connected to a device for cooling and circulating the fluid. The cerebrospinal fluid in the cerebrospinal fluid space is cooled with the flexible catheter to enable selective central nervous system cooling. The functional status of the brain and/or spinal cord is monitored, and the treatment of the brain and/or spinal cord is modified to adjust for any change in the functional status of the brain and/or spinal cord.

In some embodiments, systems, methods and devices for using passive pressure sensors to measure pressure at an inaccessible location are provided. In some embodiments, a system for determining pressure in a ventriculoperitoneal shunt implanted in a subject is provided, the system comprising: an acoustic source emitting signals over a range of frequencies; the ventriculoperitoneal shunt, comprising: a lumen that provides a conduit for cerebrospinal fluid between; and a passive acoustic element in a wall of the ventriculoperitoneal shunt filled with a gas, wherein the passive acoustic element emits a second signal at a resonant frequency that varies based on the pressure on the passive acoustic element; an acoustic receiver that detects the second signal and outputs an electrical signal that represents at least the resonant frequency; and a processor programmed to: receive the electrical signal; determine the pressure using the resonant frequency; and present the pressure using a display.

Embodiments of the present specification provide surgical methods and apparatuses to deploy at least one stent through an optic nerve sheath in order to maintain an opening/fenestration for intracranial fluid egress. The surgical method creates a fenestration, an opening, a slit, or a hole, through an optic nerve sheath of a human patient. The fenestration is created in a minimally invasive manner using an applicator, such as an endoscopic visualization apparatus, that includes a stent or shunt for deploying through the fenestration. The presently disclosed specification is indicated to treat papilledema and/or intracranial hypertension and to deliver therapeutic compositions through the optic nerve sheath.

Disclosed is a valve assembly operable to selectively control a flow or passage of a fluid. The valve assembly may be applied to any appropriate mechanism such as a hydrocephalus shunt, fluid draining sewage system, or tank holding system. The valve assembly disclosed may include a selected profile for various applications.